Join
Live feed
·
INSIDERFilingvia Quantisnow
Entrada Therapeutics Inc. logo

Chief Financial Officer Wentworth Kory James exercised 6,000 shares at a strike of $2.10 and sold $172,562 worth of shares (8,637 units at $19.98), decreasing direct ownership by 3% to 73,849 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TRDA· Entrada Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TRDA (Entrada Therapeutics Inc.) and more on Quantisnow.

Chief Financial Officer Wentworth Kory James exercised 6,000 shares at a strike of $2.10 and sold $172,562 worth of shares (8,637 units at $19.98), decreasing direct ownership by 3% to 73,849 units (SEC Form 4) | Quantisnow